IS Pharma, a specialist hospital medicines company, has launched its critical care brand, Isoplex, a balanced electrolyte plasma substitute, in the UK.
Subscribe to our email newsletter
According to the company, Isoplex will be used in situations where a patient is losing blood, such as trauma or surgery, and there is a need to increase blood volume while maintaining the body’s natural balance of minerals and salts. The majority of usage is expected to be in operating theatres, A&E and intensive care units.
IS Pharma said that it will now seek to gain regulatory approvals in other European markets based on the UK approval.
Tim Wright, CEO of IS Pharma, said: “The launch today is a further excellent example of our ability to deliver on strategy by identifying an area of significant market need and rapidly developing, registering and commercializing specialist pharmaceutical brands.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.